Update shared on 15 Dec 2025
Fair value Decreased 17%Analysts have trimmed their price target on Leonteq from CHF 19.25 to CHF 16.05, citing slightly weaker expected revenue growth, modestly lower long term profit margins, and a reduced future P E multiple despite only a marginal uptick in the assumed discount rate.
Valuation Changes
- Consensus Analyst Price Target, reduced from CHF 19.25 to CHF 16.05, a moderate downward revision of around 17 percent.
- Discount Rate, edged up slightly from 6.39 percent to approximately 6.42 percent, implying a marginally higher required return.
- Revenue Growth, trimmed modestly from about 12.72 percent to 12.45 percent, reflecting slightly softer top line expectations.
- Net Profit Margin, lowered from roughly 18.75 percent to 18.14 percent, indicating a small decline in anticipated profitability.
- Future P/E, cut from 6.82 times to about 5.92 times, representing a meaningful derating of the multiple applied to future earnings.
Have other thoughts on Leonteq?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.